AskVantage

AmplifyBio

AmplifyBio is a startup headquartered in West Jefferson, United States, founded in 2021. It has raised at least $49.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2021Founded
StartupStage
West Jefferson, United StatesHeadquarters
BiotechnologyIndustry
$49.8m+Raised (SEC filings)
EarlyFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

AmplifyBio has raised at least $49.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

AmplifyBio sits inside the Columbus region R&D ecosystem in the Global R&D Labs Directory.

Related

Questions and answers

What does AmplifyBio do?

AmplifyBio is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has AmplifyBio raised?

At least $49.8m, according to its Form D filings with the US Securities and Exchange Commission.

Where is AmplifyBio based?

AmplifyBio is headquartered in West Jefferson, United States.

When was AmplifyBio founded?

AmplifyBio was founded in 2021.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.